Cook Steven L. sold $1.0M of OMDA

Cook Steven L. (Chief Financial Officer) sold 50,950 shares of Omada Health, Inc. (OMDA) at an average of $20.31 ($19.89–$21.07, $1.03M total) across 2 trades over 2026-06-26 to 2026-06-29 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Cook Steven L.
Published Jun 30, 2026, 11:09 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Jun 30, 2026, 11:12 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$OMDA
Neutral
high confidence
Mentioned
$OMDA
Relevance
5/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$OMDANeutralLow
01

Why it matters

The newest fact is the disclosed open-market sale size, price range, and that it was executed under a pre-arranged 10b5-1 plan; there is no new operating or financial guidance in the text.

02

Market read

Primarily a sentiment/positioning datapoint for OMDA rather than a fundamental catalyst.

03

What to watch

Traders may over-weight insider sales; without concurrent guidance, earnings, or operational updates, the signal is typically weak.

Relevance 5/10Novelty 3/10Timing: filed 2026-06-30 after-hours; reflects sales dated 2026-06-26 to 2026-06-29

Background

This is an SEC Form 4 insider transaction disclosure for Omada Health, Inc. (OMDA) by its CFO.

Company-level read

Ticker impact

$OMDANeutralHigh confidence
Context

Omada Health CFO Steven L. Cook sold about 50,950 shares in open-market transactions totaling $1.03M under a 10b5-1 plan.

Expected impact

Low likelihood of a sustained price move solely from this Form 4 sale; any impact would be short-lived.

Evidence & confidence

The filing is a disclosed insider sale by an officer, explicitly tied to a pre-arranged 10b5-1 plan, with no accompanying fundamental company news.

Market effects

No clear sector read-through; this is company-specific insider transaction disclosure.

None.

None.

Counterpoint

Because the sale is under a 10b5-1 plan, it may be more about liquidity/tax planning than bearish expectations.

Key entities

  • Omada Health, Inc.

    Issuer of the Form 4 insider transaction; CFO Steven L. Cook sold shares totaling ~$1.03M.

  • Steven L. Cook

    Chief Financial Officer; sold 50,950 shares in two trades (2026-06-26 to 2026-06-29) under a 10b5-1 plan.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$OMDAHigh

Omada Health Earnings Call Signals Strong Growth Ahead

Omada Health (OMDA) reported Q3 revenue of $91M, up 34% YoY, with GAAP net income of $7M vs. a loss last year. Adjusted EBITDA rose to $12M. Management raised 2026 revenue guidance to $344M-$346M and adjusted EBITDA to $32M-$34M, citing strong demand for diabetes and hypertension programs. The company expects Q4 seasonality and GLP-1 coverage uncertainty.

$OMDAMed

What Omada Health (OMDA) Said on Its Q3 Earnings Call

Omada Health (OMDA) expects Q4 revenue to decline due to seasonal factors, with adjusted EBITDA also moderating. The company ended Q3 with $243M in cash and no debt. CEO Sean Duffy will transition to executive chair in 2027, with Shao taking over as CEO. Omada's GLP-1 Care Track showed a 6% average weight loss at 12 weeks, according to peer-reviewed research.

$OMDAMedAI 8/10

Omada Health Inc (OMDA) (Q3 2026) Earnings Call Highlights: Record Revenue, Membership

Omada Health Inc (OMDA) reported record revenue and membership growth in Q3 2026. However, new enrollments are expected to decline in Q4 due to seasonality and tough comparisons. GLP-1 market dynamics and rising healthcare costs create uncertainty for 2027. Adjusted EBITDA is expected to moderate due to increased R&D and staffing. The company aims for 20%+ growth in 2027 through expanding covered lives, improving enrollment rates, and increasing engagement.